Geng Yin

1.3k total citations
81 papers, 911 citations indexed

About

Geng Yin is a scholar working on Rheumatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Geng Yin has authored 81 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 30 papers in Epidemiology and 18 papers in Molecular Biology. Recurrent topics in Geng Yin's work include Inflammatory Myopathies and Dermatomyositis (24 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Systemic Lupus Erythematosus Research (9 papers). Geng Yin is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (24 papers), Rheumatoid Arthritis Research and Therapies (12 papers) and Systemic Lupus Erythematosus Research (9 papers). Geng Yin collaborates with scholars based in China, United States and Estonia. Geng Yin's co-authors include Qibing Xie, Chak Sing Lau, Mo Yin Mok, Huan Liu, Yuehong Chen, Ruicen Li, Min Yang, Tao Liu, Yan Liang and Yupeng Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Geng Yin

72 papers receiving 880 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geng Yin China 14 325 298 262 154 103 81 911
Huaxiang Wu China 18 478 1.5× 266 0.9× 252 1.0× 108 0.7× 104 1.0× 70 1.0k
Thomas McDonnell United Kingdom 17 356 1.1× 216 0.7× 337 1.3× 96 0.6× 64 0.6× 52 1.1k
Xin You China 17 202 0.6× 259 0.9× 220 0.8× 95 0.6× 100 1.0× 51 784
Ronan Mullan Ireland 20 496 1.5× 401 1.3× 480 1.8× 65 0.4× 75 0.7× 43 1.2k
Elizabeth Whalen United States 16 276 0.8× 314 1.1× 725 2.8× 171 1.1× 61 0.6× 27 1.4k
Felice Rivellese United Kingdom 21 452 1.4× 245 0.8× 713 2.7× 58 0.4× 50 0.5× 54 1.4k
Linchong Su China 14 183 0.6× 234 0.8× 303 1.2× 71 0.5× 100 1.0× 37 786
Takafumi Etoh Japan 23 384 1.2× 283 0.9× 677 2.6× 103 0.7× 66 0.6× 60 2.0k
Hirotsugu Ide Japan 16 312 1.0× 203 0.7× 344 1.3× 145 0.9× 54 0.5× 36 993
Hitoshi Ogasawara Japan 19 342 1.1× 229 0.8× 368 1.4× 116 0.8× 26 0.3× 55 933

Countries citing papers authored by Geng Yin

Since Specialization
Citations

This map shows the geographic impact of Geng Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geng Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geng Yin more than expected).

Fields of papers citing papers by Geng Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geng Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geng Yin. The network helps show where Geng Yin may publish in the future.

Co-authorship network of co-authors of Geng Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Geng Yin. A scholar is included among the top collaborators of Geng Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geng Yin. Geng Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yin, Geng, Hongli Zhao, & Minbo Lan. (2025). A nano drug delivery system loading drugs and chlorin e6 separately to achieve photodynamic-chemo combination therapy. Nanomedicine. 20(6). 559–570. 1 indexed citations
2.
Tang, Lan, Linlin Zhang, Geng Yin, et al.. (2025). 2D Porous Ti3C2 MXene as Anode Material for Sodium-Ion Batteries with Excellent Reaction Kinetics. Molecules. 30(5). 1100–1100. 5 indexed citations
3.
Liu, Xichuan, et al.. (2025). ZnCl₂-Induced surface texturing for long-cycling dendrite-free Zn anodes of aqueous zinc-ion batteries. Colloids and Surfaces A Physicochemical and Engineering Aspects. 726. 137911–137911.
4.
Liu, Huan, Qianwei Li, Hongjiang Liu, et al.. (2025). Suberosin attenuates rheumatoid arthritis by repolarizing macrophages and inhibiting synovitis via the JAK/STAT signaling pathway. Arthritis Research & Therapy. 27(1). 12–12. 5 indexed citations
5.
Xie, Yan, et al.. (2025). Patient reported outcomes in the FDA approved drugs for systemic rheumatic diseases (2013–2024). Health and Quality of Life Outcomes. 23(1). 52–52.
6.
Liu, Hongjiang, et al.. (2024). Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments. Journal of Autoimmunity. 148. 103286–103286. 6 indexed citations
7.
Fang, Qingqing, et al.. (2024). Safety and efficacy of phage application in bacterial decolonisation: a systematic review. The Lancet Microbe. 5(5). e489–e499. 16 indexed citations
9.
Li, Qianwei, et al.. (2023). Targeting glycolytic pathway in fibroblast-like synoviocytes for rheumatoid arthritis therapy: challenges and opportunities. Inflammation Research. 72(12). 2155–2167. 12 indexed citations
10.
Sun, Jianhong, Yuanwei Xu, Wu Yang, et al.. (2023). The diagnostic value of sST2 for myocardial fibrosis in idiopathic inflammatory myopathies in subclinical stage of cardiac involvement. Lara D. Veeken. 63(4). 1172–1179. 3 indexed citations
11.
Chen, Yuehong, Huan Liu, Zhongling Luo, et al.. (2023). Fexofenadine protects against lipopolysaccharide-induced acute lung injury by targeting cytosolic phospholipase A2. International Immunopharmacology. 116. 109637–109637. 4 indexed citations
12.
Chen, Yuehong, et al.. (2022). Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis. Frontiers in Pharmacology. 13. 768980–768980. 3 indexed citations
14.
Chen, Yuehong, et al.. (2021). The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology. 12. 632551–632551. 4 indexed citations
15.
Liu, Huan, et al.. (2021). Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases. Life Sciences. 277. 119458–119458. 40 indexed citations
17.
Chen, Yidan & Geng Yin. (2019). Swan-neck hands in a patient with ankylosing spondylitis. The Indian Journal of Medical Research. 150(6). 644–645.
18.
Yin, Geng, et al.. (2017). Identification of Palmitoleic Acid Controlled by mTOR Signaling as a Biomarker of Polymyositis. Journal of Immunology Research. 2017. 1–7. 8 indexed citations
19.
Shen, Kai, et al.. (2017). Aseptic meningitis in relapsing polychondritis: a case report and literature review. Clinical Rheumatology. 37(1). 251–255. 6 indexed citations
20.
Li, Fang, Geng Yin, Qibing Xie, & Guixiu Shi. (2014). Late-Onset Dysferlinopathy Presented as “Liver Enzyme” Abnormalities. JCR Journal of Clinical Rheumatology. 20(5). 275–277. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026